Combination of a MEK inhibitor, pimasertib (MSC1936369B), and a PI3K/mTOR inhibitor, SAR245409, in patients with advanced solid tumors: Results of a phase Ib dose-escalation trial Meeting Abstract

  

Authors:	Heist, R. S.; Gandhi, L.; Shapiro, G.; Rizvi, N. A.; Burris, H. A.; Bendell, J. C.; Baselga, J.; Yerganian, S. B.; Hsu, K.; Ogden, J.; Vincent, L.; von Richter, O.; Locatelli, G.; Asatiani, E.; Infante, J. R.
Abstract Title:	Combination of a MEK inhibitor, pimasertib (MSC1936369B), and a PI3K/mTOR inhibitor, SAR245409, in patients with advanced solid tumors: Results of a phase Ib dose-escalation trial
Meeting Title:	49th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	31
Issue:	15 Suppl.
Meeting Dates:	2013 May 31-Jun 4
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2013-05-20
Language:	English
ACCESSION:	WOS:000335419601048
PROVIDER:	wos
DOI:	10.1200/jco.2013.31.15_suppl.2530
Notes:	Meeting Abstract: 2530 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/128689